相关实验视频
Updated: Sep 11, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
846
最终阶段脏疾病的风险和托皮拉的使用
Jean-Michel Halimi1,2,3, Valentin Maisons1, Jean-Baptiste de Fréminville2,4
1Service de Néphrologie-Hypertension, Dialyse, Transplantation rénale, CHU de Tours, Tours, France.
Kidney international reports
|August 15, 2025
概括
偏头痛患者使用托皮拉与末期病 (ESKD) 和死亡风险降低有关. 然而,它也与缺血性中风或血栓栓塞的风险增加有关.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 神经学 神经学
- 心脏病学 心脏病学
背景情况:
- 托皮拉是一种常见的偏头痛预防药物,已知对处理和炎症的效应.
- 这些类药物对长期脏和心血管疾病的潜在影响尚不清楚.
研究的目的:
- 调查托皮拉使用与偏头痛患者末期病 (ESKD) 和主要心血管事件的风险之间的关联.
- 评估托皮拉对死亡率和功能标志物的影响,例如估计的淋巴球过率 (eGFR) 和白膜尿.
主要方法:
- 一项大规模的回顾性队列研究,涉及1,745,580名被诊断为偏头痛的患者.
- 倾向性得分匹配用于比较托皮拉治疗患者 (317.936) 和未接受治疗的对照患者 (317.936) 的结果.
- 随访时间延长了平均3.5年,评估了ESKD,心血管事件和死亡的风险.
主要成果:
- 托皮拉使用与ESKD (HR:0.850) 和死亡 (HR:0.827) 的风险显著降低.
- 与对照组相比,托皮拉治疗的患者表现出较慢的EGFR下降和稳定的白蛋白尿.
- 在托皮拉治疗组中观察到较高的缺血性中风或血栓塞栓症风险 (HR: 1.366),而心肌梗塞,心房动和心力衰竭的风险并没有显著不同.
结论:
- 偏头痛患者的托皮拉治疗与ESKD和死亡率的风险降低有关.
- 尽管对病进展有好处,但由于缺血性中风和血栓栓塞的风险增加,托皮拉使用需要仔细考虑.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
80
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
80
01:25Chronic Kidney Disease I: Introduction
67
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
67
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:20Acute Kidney Injury V: Interprofessional Care
44
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
01:20Antiepileptic Drugs: Potassium Channel Activators
276
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
276
01:28Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60